The Archimedes Biodegradable Biliary and Pancreatic Stents
Launched by ISTITUTO CLINICO HUMANITAS · Dec 4, 2018
Trial Information
Current as of April 27, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patients with an indication to position one ore more biliary plastic stents during ERCP
- • Patients with an indication to position a pancreatic plastic stent during ERCP
- Exclusion Criteria:
- • Age \< 18 y
- • Life expectancy \< 1 m,
- • Inability to pass a guidewire through stricture
- • Contra-indication for endoscopy or interventional radiology
- • Presence of partial gastric resection
- • Unsigned informing consent form, ICF
- • Pregnancy
- • Pseudo Klatskin tumors (metastases in the liver hilum) and gallbladder carcinoma
About Istituto Clinico Humanitas
Istituto Clinico Humanitas is a leading clinical research organization based in Italy, dedicated to advancing medical science through innovative clinical trials and research initiatives. With a strong emphasis on patient-centered care and cutting-edge methodologies, the institute collaborates with various stakeholders in the healthcare sector to develop and evaluate new therapies and treatment protocols. Its multidisciplinary team of experts is committed to ensuring the highest standards of ethical practice and scientific rigor, contributing to significant advancements in medical knowledge and improved patient outcomes.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Rozzano, Milano, Italy
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials